carnitine octanoyltransferase

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Peroxisomal Disorders (Peroxisomal Disorder) 12/01/1987 - "Inhibition of peroxisomal beta-oxidation presumably via the reduction of carnitine octanoyltransferase by chlorpromazine elicits the appearance in liver of lamellar structures resembling those seen in human peroxisomal disorders and induces accumulation of very long-chain fatty acids in plasma. "
2.	Cholestasis 04/23/1992 - "Cholestasis reduced the activity of carnitine acetyltransferase, carnitine octanoyltransferase, and carnitine palmitoyltransferase to 66 +/- 2%, 64 +/- 3%, and 40 +/- 2%, of the control, respectively. "
3.	Alzheimer Disease (Alzheimer's Disease) 06/01/1998 - "We evaluated the activities of carnitine palmitoyltransferase (CPT), carnitine octanoyltransferase (COT), and carnitine acetyltransferase (CAT) in the frontal cortex, temporal cortex, parietal cortex, hippocampus, and cerebellum of Alzheimer disease (AD) patients and normal human brains. "

1.	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)
2.	Carnitine O-Acetyltransferase
3.	Fatty Acids (Saturated Fatty Acids)
4.	Chlorpromazine (Thorazine)
5.	2- cyclohexylidenhydrazo- 4- phenyl- thiazole